The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The interleukin-6 −174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men
Open accessAbstract
AIMS: Inflammation is a key component of coronary heart disease, and genes coding for cytokines are candidates for predisposing to coronary heart disease risk. We have examined the effect of two polymorphisms (-174G>C and -572G>C) in the promoter of the interleukin-6 (IL-6) gene on risk of coronary heart disease, and on intermediate risk traits including fibrinogen and systolic blood pressure, in 2751 middle-aged healthy U.K. men. RESULTS: The -174C allele (frequency 0.43, 95% CI 0.42-0.44) was not associated with significant effects on fibrinogen levels, but was associated with a significantly (P=0.007) higher systolic blood pressure (mean mmHg (95% CI): GG=135.5 (134.3-136.7); GC=137.9 (136.9-138.9); CC= 138.0 (136.3-139.8)). This effect was of similar magnitude in smokers and non-smokers, and was greater in men in the top two tertiles of body mass index (>24.86 kg x m(-2)) than in those in the bottom tertile. Compared to those with the genotype GG, men carrying the -174C allele had a relative risk of coronary heart disease of 1.54 (95% CI 1.0-2.23, P=0.048) and this effect was greatest in smokers (compared to GG non-smokers, RR 2.66, CI 1.64-4.32). These effects remained statistically significant after adjusting for classical risk factors including blood pressure (P=0.04). The -572C allele (frequency 0.05, 0.04-0.06) was not associated with a significant effect on blood pressure, fibrinogen or relative risk of coronary heart disease. In a subset of the genotyped men (n=494), carriers of the -174C allele had higher levels of C-reactive protein than non-carriers. CONCLUSIONS: These data confirm the importance of the inflammatory system in the development of coronary heart disease. They suggest that, at least in part, the effect of the IL-6 -174G>C polymorphism on blood pressure is likely to be operating through inflammatory mechanisms, but the genotype effect on coronary heart disease risk is largely unexplained by its effect on blood pressure. The molecular mechanisms whereby genetically determined differences in plasma levels of IL-6 are having these effects remain to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243
Self-citationInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation
Terry, C. F., Loukaci, V., & Green, F. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000379200 · Cited by 800
Elevated Levels of Interleukin-6 in Unstable Angina
Biasucci, L. M., Vitelli, A., Liuzzo, G., Altamura, S., Caligiuri, G., Monaco, C., Rebuzzi, A. G., Ciliberto, G., & Maseri, A. (1996) · Circulation · doi:10.1161/01.cir.94.5.874 · Cited by 738
Weemering, M. L. (2001) · AORN Journal · doi:10.1016/s0001-2092(06)61846-2 · Cited by 433
Interleukin-6 ( IL-6 ) and the Prognosis of Abdominal Aortic Aneurysms
Jones, K. G., Brull, D. J., Brown, L. C., Sian, M., Greenhalgh, R. M., Humphries, S. E., & Powell, J. T. (2001) · Circulation · doi:10.1161/01.cir.103.18.2260 · Cited by 369
Self-citationInterleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
Rus, H. G., Vlaicu, R., & Niculescu, F. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05968-0 · Cited by 335
Duncan, M. R., & Berman, B. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483971 · Cited by 323
Minnesota Code Manual of Electrocardiographic Findings
Marty, A. T. (1983) · Critical Care Medicine · doi:10.1097/00003246-198307000-00029 · Cited by 310
Pottratz, S. T., Bellido, T., Mocharla, H., Crabb, D., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117100 · Cited by 274
Fifty years of Framingham Study contributions to understanding hypertension
Kannel, W. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000949 · Cited by 262
Molecular and cellular biology of interleukin-6 and its receptor
Keller, E. T. (1996) · Frontiers in Bioscience · doi:10.2741/a136 · Cited by 182
Increased Activation of the Haemostatic System in Men at High Risk of Fatal Coronary Heart Disease
Miller, G. J., Bauer, K. A., Barzegar, S., Cooper, J. A., & Rosenberg, R. D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650364 · Cited by 168
Woodward, M., Rumley, A., Tunstall‐Pedoe, H., & Lowe, G. D. O. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01158.x · Cited by 160
Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men
Schorr, U., Blaschke, K., Turan, S., Distler, A., & Sharma, A. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816100-00011 · Cited by 149
Sukovich, D. A., Kauser, K. Z., Shirley, F. D., DelVecchio, V., Halks‐Miller, M., & Rubanyi, G. M. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1498 · Cited by 124
Silacci, P., Dayer, J., Desgeorges, A., Peter, R. E., Manueddu, C., & Guerne, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13625 · Cited by 118
Control of aromatase activity in breast cancer cells: The role of cytokines and growth factors
Reed, M. J., Topping, L., Coldham, N. G., Purohit, A., Ghilchik, M. W., & James, V. H. T. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90264-w · Cited by 111
Stephens, J. M., Butts, M., & Pekala, P. H. (1992) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0090061 · Cited by 84
Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men
Seed, M., Ayres, K. L., Humphries, S. E., & Miller, G. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00652-5 · Cited by 49
Self-citationGreenwel, P., Iraburu, M. J., Reyes-Romero, M. A., Meraz‐Cruz, N., Casado, E., Solis-Herruzo, J. A., & Rojkind, M. (1995) · PubMed · Cited by 45
Day, I. N. M., Humphries, S. E., Richards, S., Norton, D., & Reid, M. (1995) · PubMed · Cited by 37
Self-citationInterleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen.
Takano, M., Itoh, N., Yayama, K., Yamano, M., Ohtani, R., & Okamoto, H. (1993) · PubMed · Cited by 36
Transcription Factors NF‐IL6 and APRF Involved in gp130‐mediated Signaling Pathwaya
Akira, S., Nishio, Y., Tanaka, T., Inoue, M., Matsusaka, T., WANG, X. ‐., Wei, S., Yoshida, N., & Kishimoto, T. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32310.x · Cited by 26
Angiotensinogen: an acute-phase protein?
Soden, M., Klett, C. P. R., Hasmann, T., & Hackenthal, E. (1994) · Hypertension · doi:10.1161/01.hyp.23.1_suppl.i126 · Cited by 24
Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen
Takano, M., Itoh, N., Yayama, K., Masako, Y., Ohtani, R., & Hiroshi, O. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90393-b · Cited by 24
Coagulation, fibrinolysis and cardiovascular disease
Lowe, G. D. O., & Rumley, A. (1999) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(99)90084-x · Cited by 17
Cited by
Inflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Bautista, L. E., Vera, L. M., Arenas, I. A., & Gamarra, G. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001785 · Cited by 568
The quest for genetic determinants of human longevity: challenges and insights
Christensen, K., Johnson, T. E., & Vaupel, J. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1871 · Cited by 489
Physical activity and modulation of systemic low-level inflammation
Bruunsgaard, H. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0505247 · Cited by 429
Metadata
- Authors
- Humphries, S.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-12-15
- Volume
- 22
- Issue
- 24
- Pages
- 2243-2252
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2102157578
- Cited by
- 388
- References
- 34
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.